MedTrace Logo

A Clinical Trial of the Transcendental Meditation (TM) Program on Blood Pressure, Psychological Distress, and Coping

NCT00924456 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 296

Last updated 2022-04-13

No results posted yet for this study

Summary

The purpose of this trial is to show that the Transcendental Meditation program can decrease blood pressure in young adults (college students) and is associated with decreased psychological distress and coping ability.

Conditions

  • High-normal Blood Pressure
  • Psychological Stress

Interventions

BEHAVIORAL

Transcendental Meditation program

a natural effortless mental technique

Sponsors & Collaborators

  • American University

    collaborator OTHER

  • Abramson Family Foundation

    collaborator OTHER

  • Maharishi International University

    lead OTHER

Principal Investigators

  • Robert H Schneider, M.D. · Maharishi International University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00924456 on ClinicalTrials.gov